Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001736730-25-000039
Filing Date
2025-05-13
Accepted
2025-05-13 16:26:54
Documents
79
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q camp-20250331.htm   iXBRL 10-Q 708848
2 EX-10.1 exhibit101-amendedandresta.htm EX-10.1 19674
3 EX-31.1 camp-20250331x10qexx311.htm EX-31.1 11005
4 EX-31.2 camp-20250331x10qexx312.htm EX-31.2 11121
5 EX-32.1 camp-20250331x10qexx321.htm EX-32.1 5627
6 EX-32.2 camp-20250331x10qexx322.htm EX-32.2 5632
12 camp-20250331_g1.jpg GRAPHIC 9296
  Complete submission text file 0001736730-25-000039.txt   5287019

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT camp-20250331.xsd EX-101.SCH 48024
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT camp-20250331_cal.xml EX-101.CAL 64250
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT camp-20250331_def.xml EX-101.DEF 181696
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT camp-20250331_lab.xml EX-101.LAB 578854
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT camp-20250331_pre.xml EX-101.PRE 412340
82 EXTRACTED XBRL INSTANCE DOCUMENT camp-20250331_htm.xml XML 558255
Mailing Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139 617-651-8867
Camp4 Therapeutics Corp (Filer) CIK: 0001736730 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42365 | Film No.: 25940578
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)